|
Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up |
Mosterd K, Krekels G A, Nieman F H, Ostertag J U, Essers B A, Dirksen C D, Steijlen P M, Vermeulen A, Neumann H, Kelleners-Smeets N W |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Mosterd K, Krekels G A, Nieman F H, Ostertag J U, Essers B A, Dirksen C D, Steijlen P M, Vermeulen A, Neumann H, Kelleners-Smeets N W. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncology 2008; 9(12): 1149-1156 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell /economics /surgery; Cost-Benefit Analysis; Facial Neoplasms /economics /surgery; Female; Follow-Up Studies; Health Care Costs; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mohs Surgery /economics; Neoplasm Recurrence, Local /economics /surgery; Proportional Hazards Models; Prospective Studies; Skin Neoplasms /economics /surgery; Surgical Procedures, Operative /economics /methods; Treatment Outcome AccessionNumber 22009100162 Date bibliographic record published 31/03/2009 |
|
|
|